News & Events

Wednesday March 22, 2023 This a FREE celebration of the latest 3D organoid research from around the globe! Join as and when you prefer during the day. All talks will be online with Qkine, Cambridge, UK hosting an in-person version with CN-BIO too! Register to attend on Zoom or LinkedIn. Register Here

 Come by the Corning® Tutorial at SLAS 2023 on February 27th to hear how BennuBio couples Corning® Elplasia® 3D culture technology with the Velocyt® LP cytometer to easily image hundreds to thousands of intact homogeneous spheroids for a variety of applications. Oh, by the way, you also can recover all your spheroids, intact and unadulterated, after acquisition by the Velocyt cytometer for…

BennuBio announced it received the Society for Laboratory Automation and Screening (SLAS) prestigious Ignite award at SLAS’s annual International Conference and Exhibition in Boston, MA on February 9, 2022. The SLAS Ignite Award recognizes the best start-up or emerging company exhibiting within Innovation AveNEW, a specially designated area for start-ups and emerging companies within the SLAS International Conference and Exhibition. Seventeen…

In response to continuing success of their novel large particle flow cytometer, BennuBio has moved to a larger facility to consolidate engineering, administrative and laboratory in one building. Formerly located in the WESST Enterprise Center, and with shared laboratory space at TriCore Reference Laboratories, BennuBio is now located at 6610 Gulton Ct. NE in Albuquerque. CEO, Steven Graves stated, “A larger…

Medical device startup BennuBio Inc. won a $1 million National Institutes of Health grant to add rapid analysis capability for complex, three-dimensional cellular “spheroids” to its existing cell-screening technology.

BennuBio was awarded an NIH (National Institute of Health) SBIR (Small Business Innovation Research) grant that will advance the Company’s development of a novel analytic tool for 3D tissue models.

BennuBio, Inc., a provider of advanced cell and particle instrumentation for the life science market, today announced it has closed on $5 million of a $7 million financing round.

The Series B financing was led by new investor Co-Win Ventures with additional investment by existing investors Tramway Venture Partners, Cottonwood Technology Fund, and Sun Mountain Capital. In connection with the financing, Xin Huang of Co-Win Ventures will join BennuBio’s Board of Directors.

The Series B financing was led by new investor Co-Win Ventures with additional investment by existing investors Tramway Venture Partners, Cottonwood Technology Fund, and Sun Mountain Capital. In connection with the financing, Xin Huang of Co-Win Ventures will join BennuBio’s Board of Directors.

Governor Susana Martinez Announces $1.5 Million in Series A Funding for Local Tech Company BennuBio Receives Catalyst Fund Investment Albuquerque, N.M. – Today, Governor Susana Martinez announced that BennuBio, Inc. will receive a Catalyst Fund investment of $1.5 million from Tramway Venture Partners, Cottonwood Technology Fund and Sun Mountain Capital. This investment will help BennuBio develop high throughput flow cytometers. BennuBio is…